docetaxel anhydrous has been researched along with s-allylmercaptocysteine in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (s-allylmercaptocysteine) | Trials (s-allylmercaptocysteine) | Recent Studies (post-2010) (s-allylmercaptocysteine) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 53 | 0 | 30 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiu, YT; Chua, CW; Howard, EW; Lee, DT; Wang, X; Wong, YC | 1 |
1 other study(ies) available for docetaxel anhydrous and s-allylmercaptocysteine
| Article | Year |
|---|---|
Evidence of a novel docetaxel sensitizer, garlic-derived S-allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cadherins; Cell Division; Cell Line, Tumor; Cysteine; Docetaxel; Down-Regulation; Drug Synergism; Flow Cytometry; G2 Phase; Garlic; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Mice; Mice, Nude; Neoplasms, Experimental; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Taxoids; Transplantation, Heterologous; Tumor Stem Cell Assay; Up-Regulation | 2008 |